Home › Myeloproliferative Neoplasms › New Mexico › Albuquerque
Myeloproliferative Neoplasms clinical trials in Albuquerque, NM
4 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around Albuquerque (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- University of New Mexico Cancer Center, Albuquerque
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- University of New Mexico Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Albuquerque
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Miami, FL10 studies
- Milwaukee, WI10 studies
- Durham, NC9 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Chicago, IL9 studies
- Portland, OR8 studies
- Cleveland, OH8 studies
- Atlanta, GA8 studies
Other studies in Albuquerque
- Non-Small Cell Lung Cancer18 studies
- Breast Cancer17 studies
- Ovarian Cancer15 studies
- Cancer (all types)14 studies
- Lung Cancer14 studies
- Metastatic Cancer12 studies
- Endometrial Cancer12 studies
- Type 2 Diabetes11 studies
- Cardiovascular Disease10 studies
- Melanoma9 studies
- Acute Myeloid Leukemia9 studies
- Prostate Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.